Annual Report

Overview

The report describes a transformative 2023, with consolidated revenue more than doubling to DKK 7,062 million and EBITDA reaching DKK 2,615 million. The company expanded its global organization through the Emergent BioSolutions acquisition, adding travel vaccines, manufacturing and research capabilities. Sustainability disclosures introduced Scope 3 reporting and reiterated a Net Zero emissions commitment by 2050.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 6 March 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Provider
Level
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services